MARY YAGER: Open Payments
NPI 1649954348 · LATHAM, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$571 in 27 payments from 13 companies in 2025. Trend: 2023 $52 · 2024 $671 · 2025 $571
Food & beverage: $571
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $173 |
| Novo Nordisk Inc | 4 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $60 |
| ABBVIE INC. | 2 | $43 |
| Lilly USA, LLC | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $19 |
Products named: AIRSUPRA, Wegovy, TRINTELLIX, Kerendia, UBRELVY, REXULTI, MOUNJARO, BREZTRI.
Industry payments across NY — which companies pay providers there.
